These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28518410)

  • 1. Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma.
    Acharya A; Markar SR; Sodergren MH; Malietzis G; Darzi A; Athanasiou T; Khan AZ
    Br J Surg; 2017 Jun; 104(7):814-822. PubMed ID: 28518410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
    Neoptolemos JP; Moore MJ; Cox TF; Valle JW; Palmer DH; McDonald AC; Carter R; Tebbutt NC; Dervenis C; Smith D; Glimelius B; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Ghaneh P; Halloran CM; Lerch MM; Oláh A; Rawcliffe CL; Verbeke CS; Campbell F; Büchler MW;
    JAMA; 2012 Jul; 308(2):147-56. PubMed ID: 22782416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study.
    Uijterwijk BA; Lemmers DH; Ghidini M; Wilmink JW; Zaniboni A; Fusai GK; Zerbi A; Koerkamp BG; Luyer M; Ghorbani P; Salvia R; White S; Ielpo B; Goh BKP; Boggi U; Kazemier G; House MG; Mavroeidis VK; Björnsson B; Mazzola M; Serradilla M; Korkolis D; Alseidi A; Roberts KJ; Soonawalla Z; Pessaux P; Fisher WE; Koek S; Kent TS; Vladimirov M; Bolm L; Jamieson N; Dalla Valle R; Kleeff J; Mazzotta A; Suarez Muñoz MA; Cabús SS; Ball CG; Berger AC; Ferarri C; Besselink MG; Hilal MA;
    Br J Cancer; 2024 Jul; 131(1):117-125. PubMed ID: 38806725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
    Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
    Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
    Byrling J; Ghazi S; Andersson B
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.
    Jiang ZQ; Varadhachary G; Wang X; Kopetz S; Lee JE; Wang H; Shroff R; Katz M; Wolff RA; Fleming J; Overman MJ
    Ann Oncol; 2013 Sep; 24(9):2349-53. PubMed ID: 23704197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
    Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
    Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of periampullary carcinoma.
    Robertson JF; Imrie CW; Hole DJ; Carter DC; Blumgart LH
    Br J Surg; 1987 Sep; 74(9):816-9. PubMed ID: 3664249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
    Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Schirmer CB; Renolen A; Borgen EF; Naume B; Wiedswang G
    Ann Surg; 2020 Mar; 271(3):549-558. PubMed ID: 30216219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
    Klinkenbijl JH; Jeekel J; Sahmoud T; van Pel R; Couvreur ML; Veenhof CH; Arnaud JP; Gonzalez DG; de Wit LT; Hennipman A; Wils J
    Ann Surg; 1999 Dec; 230(6):776-82; discussion 782-4. PubMed ID: 10615932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.
    Moekotte AL; Malleo G; van Roessel S; Bonds M; Halimi A; Zarantonello L; Napoli N; Dreyer SB; Wellner UF; Bolm L; Mavroeidis VK; Robinson S; Khalil K; Ferraro D; Mortimer MC; Harris S; Al-Sarireh B; Fusai GK; Roberts KJ; Fontana M; White SA; Soonawalla Z; Jamieson NB; Boggi U; Alseidi A; Shablak A; Wilmink JW; Primrose JN; Salvia R; Bassi C; Besselink MG; Abu Hilal M
    Br J Surg; 2020 Aug; 107(9):1171-1182. PubMed ID: 32259295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
    Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
    Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer.
    Pomianowska E; Grzyb K; Westgaard A; Clausen OP; Gladhaug IP
    Eur J Surg Oncol; 2012 Nov; 38(11):1043-50. PubMed ID: 22883964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for true ampullary cancer: a systematic review.
    Bonet M; Rodrigo A; Vázquez S; Carrizo V; Vilardell F; Mira M
    Clin Transl Oncol; 2020 Aug; 22(8):1407-1413. PubMed ID: 31927720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
    Erdmann JI; Morak MJ; Duivenvoorden HJ; van Dekken H; Kazemier G; Kok NF; van Eijck CH
    HPB (Oxford); 2015 Jul; 17(7):573-9. PubMed ID: 25800041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.